Kiritkumar Patel, MD
Cardiovascular Disease · Bloomfield Hills, MINPI 1003871294
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,761 of the $17,341 with a category attached, or 62.1%. Medtronic accounts for 64.9% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2019 at $7,639 and has fallen 88.6% since, to $868 in 2025.
Across 286 payments — averaging $60.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Endologix LLC$1K
- Abbott$1K
- Bolton Medical Inc$554
- Abiomed$487
- Novartis$304
- plus $2K from 30 others
Across 110 payments — averaging $5987.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$589K
- Shockwave Medical, Inc$39K
- Boehringer Ingelheim International GmbH$23K
- Boehringer Ingelheim Pharma GmbH & Co.kg$7K
What the payments were for
- Travel & lodging$6,49237%
- Food & beverage$10,76162%
- Education$140%
- Other$730%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 112 | $11,257 |
| Endologix LLC | 44 | $1,453 |
| Abbott | 33 | $1,430 |
| Bolton Medical Inc | 3 | $554 |
| Abiomed | 5 | $487 |
| Novartis | 13 | $304 |
| Kestra Medical Technology Services, Inc. | 9 | $241 |
| Biotronik Inc. | 2 | $183 |
| Edwards Lifesciences | 2 | $183 |
| Shockwave Medical, Inc | 2 | $159 |
| Lexicon Pharmaceuticals, Inc. | 3 | $138 |
| E.r. Squibb & Sons, L.L.C. | 15 | $131 |
| Baxter Healthcare | 2 | $89 |
| Pfizer | 4 | $82 |
| Amgen | 4 | $64 |
| Cleerly, Inc. | 2 | $64 |
| Merck | 3 | $62 |
| Johnson & Johnson | 4 | $55 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $50 |
| Heartflow, Inc. | 1 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Boston Scientific | 2 | $27 |
| AstraZeneca | 2 | $25 |
| Novo Nordisk | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Cvrx, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Terumo Medical Corporation | 1 | $19 |
| Atricure, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Cordis US CORP. | 1 | $15 |
| Penumbra, Inc. | 1 | $13 |
| Cardinal Health 200 LLC | 1 | $12 |
| W. L. Gore & Associates, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Resolute$5,473
- SYMPLICITY G3$920
- CoreValve Evolut$732
- COREVALVE EVOLUT R$659
- Relay Grafts$503
- Impella$374
- MitraClip$373
- Ovation$288
- Mitra Clip system$279
- Solia$159
- Acticor$159
- Rivacor$159
- Edora$159
- BioMonitor$159
- Inpefa$125
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$118
- Dragonfly OCT$116
- Assure WCD$103
How this compares
$17,341 in reported general payments places this provider in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 856 | $1,101,483 |
| EntrestoSacubitril/Valsartan | 444 | $586,709 |
| JardianceEmpagliflozin | 231 | $323,584 |
| FarxigaDapagliflozin Propanediol | 231 | $289,532 |
| Repatha SureclickEvolocumab | 208 | $214,773 |
| XareltoRivaroxaban | 122 | $155,316 |
| Praluent PenAlirocumab | 96 | $88,555 |
| BrilintaTicagrelor | 49 | $42,935 |
| Atorvastatin Calcium | 1,851 | $31,926 |
| ClopidogrelClopidogrel Bisulfate | 1,326 | $30,093 |
| Metoprolol Succinate | 1,405 | $25,463 |
| Ranolazine ErRanolazine | 120 | $16,672 |
| CorlanorIvabradine Hcl | 15 | $15,508 |
| Icosapent Ethyl | 25 | $12,781 |
| Rosuvastatin Calcium | 607 | $11,812 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $82 | $1,101,483856 claims |
| NovartisEntresto | $304 | $586,709444 claims |
| AstraZenecaFarxiga, Brilinta | $25 | $332,467280 claims |
| Johnson & JohnsonXarelto | $55 | $155,316122 claims |
| AmgenCorlanor | $64 | $15,50815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Bloomfield Hills
- Michele DegregorioBloomfield Hills$102K
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.